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Aim To investigate whether administration of nifedipine 
has considerable therapeutic effect in morphine-depen-
dent rats.
Methods Sixty animals were randomized into control, 
morphine, morphine plus nifedipine, and morphine plus 
dimethyl sulfoxide (DMSO, as nifedipine soluble) groups. 
Each group consisted of two subgroups, with and with-
out heart injury. The groups were treated with incremental 
doses of morphine or morphine plus nifedipine daily for 7 
days. Myocardial injury was induced by isoproterenol (50 
mg/kg i.p.) on the day 7. On the day 8, the heart rate (HR), 
blood pressure (BP), rate-pressure product (RPP), and the 
plasma level of cardiac troponin I were measured and the 
hearts were histopathologically examined.
Results In morphine-dependent rats, nifedipine adminis-
tration was associated with a significantly higher decrease 
in the plasma level of cardiac troponin I than the adminis-
tration of morphine alone. This finding was also significant 
in dependent animals that received only DMSO. HR, BP, 
RPP, and histopathological indices did not show significant 
changes in the presence of nifedipine.
Conclusion Administration of nifedipine failed to show a 
significant therapeutic effect in morphine-dependent rats, 
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Acute and chronic morphine administration has cardiopro-
tective effect (1,2). Morphine is also effective in relieving 
chest pain (3), pulmonary edema, and heart failure after 
myocardial infarction (4). Morphine dependency is associ-
ated with an increase of L-type Ca2+ channels’ expression, 
increased calcium entrance to cells, and enhanced basal-
free intracellular Ca2+ concentration in the central nervous 
system (5-7).
Calcium and cardiac L-type Ca2+ channels have a funda-
mental role in heart activity (8,9). The calcium channel 
antagonists/blockers (CCAs/CCBs) are a heterogeneous 
group of drugs used to treat cardiovascular diseases, in-
cluding hypertension, angina pectoris, peripheral vascu-
lar disorders, and some arrhythmic conditions (10). Three 
main classes of CCAs include dihydropyridine, phenyla-
lkylamine, and benzothiazepine calcium channel block-
ers. Dihydropyridine calcium channel blockers such as 
nifedipine are recommended to reduce systemic vascu-
lar resistance and arterial pressure, but their vasodilation 
and hypotension effects usually lead to reflex tachycardia 
(11). Phenylalkylamines, eg, verapamil, cause negative in-
otropy, coronotropy, and dromotropy, reduce myocar-
dial oxygen demand, and reverse coronary vasospasm. 
Therefore, they are often used to treat angina. They have 
minimal vasodilatory effects compared with dihydro-
pyridines and cause fewer reflex tachycardias (11). Ben-
zothiazepine calcium channel blockers such as diltiazem 
show both cardiac depressant and vasodilator actions. 
They are able to reduce arterial pressure without produc-
ing the reflex cardiac stimulation caused by dihydropyri-
dines (11).
The L-type CCBs increase morphine analgesia (12,13) and 
prevent the development of opioid tolerance and also at-
tenuate the signs of physical dependence (14,15). Despite 
abundant evidence on the cross interaction between mor-
phine and CCAs effects in central and peripheral nervous 
system (12-15), the cardiovascular outcome of CCAs ad-
ministration in morphine dependency has received less at-
tention. However, in some clinical conditions simultaneous 
long-term administration of calcium channel antagonists 
and morphine may be inevitable. In a previous study, we 
demonstrated that sub-chronic co-administration of mor-
phine and verapamil, a phenylalkylamine, had additive car-
dioprotective effect when compared with each of them 
alone (16).
Since there is evidence on cardioprotective role of nife-
dipine on isoproterenol-induced myocardial injury 
(17), the present study was conducted to elucidate wheth-
er nifedipine had cardiovascular effect in morphine-de-
pendent rats, especially those with heart injury.
MaterialS and MethodS
Chemicals
Morphine sulfate (Temad, Tehran, Iran), sodium thiopental 
(Biocheme, Kundl, Austria), and isoproterenol (Sigma, Mis-
souri, USA) were dissolved in physiological saline and nife-
dipine (Sigma) was dissolved in dimethyl sulfoxide (DMSO) 
plus saline.
animal groups
Experiments were performed on 60 male Wistar rats 
aged 3 months weighing 250-300 g. Animals were ran-
domly divided into five main groups, with no difference 
in mean weight, and each including two subgroups of 
rats with or without heart injury. Each subgroup includ-
ed 7-9 animals. The morphine group was treated with in-
creasing doses of morphine sulfate solution of 10, 10, 12, 
15, 15, 20, 20 mg/kg daily i.p. for seven days (16). Mor-
phine dependency was confirmed by withdrawal behav-
iors following the injection of naloxon HCL 2 mg/kg i.p. to 
some animals. These behaviors include teeth chattering, 
chewing, paw tremor, ptosis, writhing, wet-dog shakes, 
head shakes, diarrhea, ejaculation, erection, and weight 
loss (18). Morphine + nifedipine (M+NIF) group received 
nifedipine 10 mg/kg. i.p. daily (19) 30 minutes after mor-
phine injection. M+DMSO group received morphine plus 
dimethyl sulfoxide (DMSO) but without nifedipine. Con-
trol group received equivalent volume of normal saline. 
Control subgroup that received isoproterenol was called 
ISO group. Other subgroups that received isoproterenol 
were added “ISO” to their names (Tables 1 and 2). All ex-
periments followed the guidelines for conducting animal 
studies (ethics committee permission No 86/123KA – Ker-
man University of Medical Sciences).
experimental protocol, sampling, and recording
On the day 7, one hour after having received the last dose 
of drugs, isoproterenol (50 mg/kg i.p.) was injected to in-
duce cardiac injury (16,20). After 3 hours, a blood sample 
was taken by retro-orbital puncture from all animals and 
centrifuged, and serums were stored at -20°C for a maxi-
mum of 2 weeks until troponin I, a biochemical marker of 
myocardial injury, was measured using an enzyme-linked 
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fluorescent immunoassay by VIDAS instrument and the re-
lated kit (16).
On the day 8, animals were deeply anesthetized with so-
dium thiopental (50 mg/kg i.p.) and their trachea was can-
nulated. During the entire experiment, animals breathed 
spontaneously. A heparinized saline-filled cannula (15 
units/mL) was inserted and fixed into the right carotid ar-
tery and subsequently connected to a pressure transducer 
and physiograph (Beckman R612, Beckman Instr., Schiller 
Park, IL, USA) for heart rate and arterial blood pressure (BP) 
recordings. Mean arterial pressure (MAP) was calculated ac-
cording to “MAP=Pd+ (Ps-Pd)/3 formula,” where Pd stands 
for diastolic and Ps for systolic arterial pressure. Rate-pres-
sure product (RPP), an index of myocardial oxygen de-
mand, was estimated by the product of the heart rate and 
mean arterial pressure [(MAP*heart rate)/1000] (21,22).
histopathological study
After heart rate and blood pressure recordings had been 
made, the animals were killed under deep anesthesia and 
their hearts were removed, fixed in 10% buffered forma-
lin, and embedded in paraffin after tissue processing. Five 
micron-thick sections were prepared, stained with hema-
toxylin and eosin, and examined microscopically by two 
pathologists blinded to animal grouping. The lesions were 
graded as 0) nil; 1) minimum (focal myocytes damage); 2) 
mild (small multifocal degeneration with slight degree of 
inflammatory process); 3) moderate (extensive myofibrillar 
degeneration and/or diffuse inflammatory process); and 4) 
severe (necrosis with diffuse inflammatory process) (23).
Statistical analysis
The values are expressed as mean ± standard error of the 
mean. Data analysis was performed by SPSS, version 14 
(SPSS Inc., Chicago, IL, USA). One-way ANOVA followed by 
post hoc Tukey test was used to compare the quantitative 
data. Comparisons of histopathological findings were car-
ried out using the non parametric Kruskal-Wallis and pair-
wise differences by the Mann-Whitney U-test (16). P value 
<0.05 was considered as statistically significant.
reSultS
hemodynamic findings
There was a non significant reduction in arterial blood 
pressure in the morphine subgroup without injury com-
pared to control group, regardless of nifedipine or DMSO 
treatment (Table 1). However, in the heart injury subgroup, 
morphine, M+NIF, and M+DMSO groups showed a signifi-
cant reduction in systolic, diastolic, and MAP. Morphine 
with and without DMSO decreased the heart rate com-
pared to control group (P < 0.05), but DMSO increased it in 
animals with heart injury.
In addition, all morphine-dependent animals with heart in-
jury, M+ISO, M+DMSO+ISO, and M+NIF+ISO showed a sig-
nificant reduction in RPP when compared with ISO group 
(Table 1). On the other hand, there was no significant dif-
ference in RPP value between morphine group and nife-
dipine + morphine group, both in animals with and with-
out heart injury.
table 1. blood pressure, heart rate, and pressure rate product in each group of animals
Groups 











Control (n = 7) 128 ± 5 94 ± 4 105 ± 4 386 ± 14 41 ± 3
ISO (n = 7) 132 ± 6 95 ± 5 107 ± 6 403 ± 8 43 ± 2
M (n = 9) 111 ± 7 82 ± 9  92 ± 8 333 ± 13† 31 ± 4†
M+ISO (n = 9) 106 ± 5‡ 64 ± 5‡  78 ± 5‡ 363 ± 12 29 ± 3‡
M+NIF (n = 7) 110 ± 8 79 ± 7  90 ± 7 356 ± 16 32 ± 4
M+NIF+ISO (n = 7) 109 ± 10§ 68 ± 9‡  82 ± 9‡ 383 ± 23 31 ± 4§
M+DMSO (n = 7) 109 ± 9 79 ± 9  89 ± 9 337 ± 22† 31 ± 5†
M+DMSO+ISO (n = 7)  95 ± 7‡ 59 ± 5‡ II  71 ± 5‡ 417 ± 14¶** 30 ± 3‡
*abbreviations: M – morphine; niF – nifedipine; iSo – isoproterenol; dMSo – dimethyl sulfoxide.
†P < 0.05 compared with control group.
‡P < 0.01 compared with iSo group.
§P < 0.05 compared with iSo group.
iiP < 0.05 compared with M+dMSo group.
¶P < 0.01 compared with M+dMSo group.
**P < 0.05 compared with M+iSo group.
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Plasma cardiac troponin i levels
Cardiac injury was associated with a significant increase in 
plasma cardiac troponin I levels in all animal groups when 
compared with their corresponding control subgroups. This 
increase was lower in M+DMSO (P < 0.05) and M+NIF sub-
groups (P < 0.01 vs their corresponding control subgroups) 
and was higher for M and control subgroups (P < 0.001 vs 
their corresponding control subgroups) (Figure 1). Com-
parisons among injury subgroups showed a significant de-
cline in troponin I levels in dependent animals in the pres-
ence of DMSO or nifedipine when compared with control 
or morphine groups (P < 0.01). However, animals with mor-
phine dependency alone did not show a significant differ-
ence compared to control group (Figure 1).
histopathological findings
Control group showed normal appearance of myocardial 
tissue. Isoproterenol injection was associated with vary-
ing degrees of muscle heart damage in different groups 
(P < 0.01 for ISO and M+ISO vs control and M groups, re-
spectively, and P < 0.05 for other groups compared to rela-
tive control). The highest level of damage was observed 
in the control subgroup with cardiac injury. In this sub-
group, 50% of animals showed cellular necrosis with dif-
fuse inflammatory process (Table 1). On the other hand, 
pre-treatment with morphine, alone and concomitant 
with nifedipine or DMSO, non significantly attenuated the 
severity of myocardial damage (Table 2 and Figure 2). In 
addition, coronary dilatation and tissue congestion were 
dominant phenomena in animals that were treated with 
morphine with or without nifedipine, especially in heart in-
jury groups (Figure 2).
diSCuSSion
This study found that nifedipine had a mild cardioprotec-
tive role in rats with heart injury, which was enhanced by 
DMSO, and did not have a significant effect on hemody-
namic, myocardial oxygen consumption and biochemical 
and histopathological indicators in morphine-dependent 
rats with or without heart injury.
The cardioprotective effect of morphine, confirmed by 
lower levels of myocardial damage, was also found in pre-
vious studies (1,2). However, morphine had no effect on 
serum cardiac troponin I level as an important biomarker 
of cardiac damage.
Morphine fails to reduce LDH release following ischemia/
reperfusion but improves heart contractility (2). In ad-
dition, in two previous studies we found that opium de-
creased isoproterenol-induced heart lesions but was un-
able to reduce serum levels of cardiac troponin I (24,25). 
Moreover, it was reported that morphine therapy in acute 
table 2. heart injury histopathological scores in each group 
of animals*
no. of animals with myocardial 
pathology scores†
Groups n 0 1 2 3 4 Mean
Control 7 7 0 0 0 0 0
ISO 7 0 0 3 1 3 3‡
M 9 7 2 0 0 0 0.22
M+ISO 9 0 1 5 1 2 2.44§
M+NIF 7 3 3 0 1 0 0.86
M+NIF+ISO 7 0 1 2 2 2 2.71II
M+DMSO 7 4 1 2 0 0 0.71
M+DMSO+ISO 7 0 2 3 1 1 2.14¶
*abbreviations: iSo – isoproterenol; M – morphine; niF – nifedipine; 
dMSo –dimethyl sulfoxide.
†0 – nil, 1 – minimum (focal myocytes damage), 2 – mild (small 
multifocal degeneration with slight degree of inflammatory process), 
3 – moderate (extensive myofibrillar degeneration and/or diffuse 
inflammatory process), 4 – severe (necrosis with diffuse inflammatory 
process). although the number of animals with severe lesion (score 
of 4) was higher in the iSo group, there was no significant difference 
among animals with heart injury.
‡P < 0.01 compared with control.
§P < 0.01 compared with M group.
iiP < 0.05 compared with M+niF group.
¶P < 0.05 compared with M+dMSo group.
FiGure 1. Plasma cardiac troponin i levels in groups of animals. 
the results are presented are mean ± standard error of the 
mean. n = 6-7, normal – subgroup without isoproterenol-
induced cardiac injury; iSo – subgroup with isoproterenol 
induced cardiac injury; Ctl – control; M – morphine; niF 
– nifedipine; dMSo – dimethyl sulfoxide. †P < 0.05, ‡P < 0.01, 
‡‡P < 0.001 compared with relative normal group. ¶P < 0.01 com-
pared with the corresponding Ctl group. §P < 0.01 compared 
with morphine group. normal – closed bars; iSo – gray bars.
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decompensated heart failure significantly increased serum 
cardiac troponin I levels (26).
The mismatch between troponin I level and the extent 
of heart damage in morphine-dependent animals was 
observed in previous studies (16,24-26), as well as in this 
study. However, to the best of our knowledge, no study ex-
plained this inconsistency and further studies are needed. 
The cardioprotective effect of morphine may be attributed 
to peripheral vasodilatation and negative chronotropy sec-
ondary to vagal tone amplification and sympathetic tone 
diminution by morphine (27), which in turn reduces the 
cardiac workload and oxygen demand. This study showed 
that isoproterenol increased the heart rate and RPP to 
some extent. However, chronic morphine use decreased 
the heart rate and RPP and also induced coronary vaso-
dilatation, as judged by coronary dilatation in histological 
examination.
The question remains as to why the combination of mor-
phine and nifedipine did not show excess cardioprotec-
tive effect. Nifedipine consumption is associated with re-
flex tachycardia, which occurs due to the vasodilatation 
and hypotension effects of this drug (11) and hence is not 
usually prescribed to treat angina. Our finding is consistent 
with previous findings on reflex tachycardia effect of nife-
dipine. There was an increased trend in heart rate and RPP 
in M+NIF group with/without heart injury when compared 
with the corresponding morphine group. However, these 
differences were not significant and the collective effect 
of these two changes may be attenuated by the positive 
effect of morphine as appeared in histopathological find-
ings. The other possibility is the interaction of morphine 
and nifedipine on heart L-type Ca2+ channels. In the central 
nervous system, chronic use of morphine enhances the L-
type Ca2+ channels’ expression, augments the calcium entry 
in to cell, and increases basal free intracellular Ca2+ concen-
tration (5-7). Other effects of morphine are prolongation of 
action potential by augmentation of L-type calcium cur-
rent (28) and increase in heart myofilament sensitivity to 
calcium (29). On the other hand, chronic administration of 
nifedipine up-regulates L-type calcium channels receptors 
of the heart (30,31). This recently discovered effect of nife-
dipine, along with reflex tachycardia, can increase the con-
centration of free intracellular calcium that is triggered by 
morphine and hence modulate the cardioprotective effect 
of morphine.
It seems that the reduction of troponin I level in M+NIF 
group does not result from nifedipine effect, but is aris-
ing from solvent (DMSO) effect. Because of this, the con-
sumption of DMSO was associated with a decrease in 
both troponin I level and the severity of heart damage. 
In addition, the histopathological index is a more reliable 
indicator of the extent and severity of heart damage than 
other indices.
This finding is also consistent with studies that have 
shown neuroprotective (32,33) and cardioprotective 
FiGure 2. hematoxylin and eosin stained sections of heart 
tissue in different animal groups. (A) Control group heart 
section with normal appearance of cardiac myofibers. (B) 
Control group that received isoproterenol (iSo) showing severe 
myocardial degeneration. (C) normal architecture of myocytes 
in morphine group. (D) degeneration, edema, and moderate 
degree of fibroblastic proliferation and inflammatory process 
in morphine subgroup that received isoproterenol. (E) heart 
sections from morphine + nifedipine group (M+niF) showing 
prominence coronary vasodilatation. (F) a section from M+niF 
after isoproterenol-induced heart injury. degeneration, edema, 
inflammatory process, and fibroblastic proliferation are obvi-
ous. (G) and (H) are sections from morphine+dMSo (M+dMSo) 
subgroups with/without myocardial injury, respectively.
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(33) role of DMSO. It is reported that DMSO has an effect on 
blocking Na+ and Ca2+ entry into the cells (34,35). Since a 
high dose of isoproterenol causes cytosolic calcium over-
load that mediated through the calcium channels, DMSO 
administration may prevent this inward cellular ion flux 
and hence attenuate heart damage.
In conclusion, our study suggested that in the presence of 
morphine dependency, nifedipine administration had no 
considerable cardiovascular effect. This finding may give a 
new perspective on the application of dihydropyridine cal-
cium channel blockers in narcotic dependent patients.
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